[{"data": {"name": "Moving things forward in Hodgkin lymphoma", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Paul J. Br\u00f6ckelmann", "@type": "Person"}, {"name": "Boris B\u00f6ll", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://f1000research.com/articles/7-1786/v1/pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "F1000 Research Ltd", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.12688/f1000research.16077.1", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCbnfAgBmv3ue-CTXJPqLFPo9Mo-CDLRW24efD6Wi-CRfkuijWLFnGq", "propertyID": "ISCC"}], "datePublished": "2018-11-13"}, "schema": "schema.org", "mediatype": "application/ld+json"}]